Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Aprea Therapeutics, Inc. APRE
$3.81
-$0.09 (-2.43%)
На 18:01, 12 мая 2023
-21.26%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
14524390.00000000
-
week52high
25.80
-
week52low
0.47
-
Revenue
0
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-68.96000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Wedbush | Outperform | 08 июл 2022 г. | |
| RBC Capital | Sector Perform | Sector Perform | 16 мар 2022 г. |
| HC Wainwright & Co. | Neutral | Neutral | 16 мар 2022 г. |
| JP Morgan | Underweight | Neutral | 20 авг 2021 г. |
| HC Wainwright & Co. | Neutral | Neutral | 16 авг 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Hamill John P. | A | 539758 | 539758 | 30 янв 2023 г. |
| Hamill John P. | A | 269879 | 269879 | 30 янв 2023 г. |
| SCHADE CHRISTIAN S | A | 47600 | 47600 | 28 июл 2022 г. |
| SCHADE CHRISTIAN S | A | 259246 | 32400 | 28 июл 2022 г. |
| Seizinger Bernd R. | A | 29575 | 29575 | 28 июл 2022 г. |
| Seizinger Bernd R. | A | 324575 | 5995 | 28 июл 2022 г. |
| HENNEMAN JOHN B III | A | 29575 | 29575 | 28 июл 2022 г. |
| HENNEMAN JOHN B III | A | 15605 | 5995 | 28 июл 2022 г. |
| Korbel Gregory Alan | A | 35700 | 35700 | 28 июл 2022 г. |
| Korbel Gregory Alan | A | 45762 | 24300 | 28 июл 2022 г. |
Новостная лента
Best Penny Stocks To Buy? 4 To Watch In January 2023
PennyStocks
11 янв 2023 г. в 08:51
4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why The Stock Market Is Down Today & 4 Penny Stocks To Watch
PennyStocks
13 сент 2022 г. в 12:47
Red Hot Biotech Penny Stocks To Watch Right Now The post Why The Stock Market Is Down Today & 4 Penny Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aprea Therapeutics (APRE) Stock Soars as Wedbush Sets $3 Price Target
InvestorPlace
08 июл 2022 г. в 12:56
Wedbush analyst Robert Driscoll just gave a huge upside target for APRE stock. Here's why this is significant for the biotech sector.